Biopolymeric
micelles derived from bioinspired amphiphilic polymers
are drawing noteworthy attention as carriers for hydrophobic drugs
since they possess a hydrophobic core and a hydrophilic cell. Herein,
a hydrophobic monomer N-Boc glycine-hydroxy methyl methacrylate (Gly-HEMA)
has been synthesized by chemical modification of N-Boc glycine. This
monomer has further been grafted through reversible addition–fragmentation
chain transfer (RAFT) polymerization on the backbone of sodium alginate
(hydrophilic) to obtain an amphiphilic copolymer with an attached
hydrophobic segment. The controlled polymerization is assessed using
advanced polymer chromatographic (APC) analysis with a narrow dispersity.
The critical micelle concentration (CMC) of the developed copolymer
[i.e., Alg-g-p(Gly-HEMA)] has been determined by
surface tension measurement and photoluminescence (PL) spectroscopic
and dynamic light scattering (DLS) analyses. The size and morphology
of the developed micelle have been investigated by field emission
scanning electron microscopy (FESEM) and high-resolution transmission
electron microscopy (HRTEM) analyses, which reveal that the size of
the copolymeric micelle is ∼200 nm with a spherical shape.
Alg-g-p(Gly-HEMA) has demonstrated pH-responsive
reversible micellization behavior. The process of micellization to
phase separation and vice versa can be controlled just by altering
the pH. The formed micelle is able to uptake the hydrophobic drug
indomethacin (% of loading: ∼34%) and release it in a controlled
manner, as apparent from an in vitro study.